Quinolone antibacterial drugs inhibit bacterial DNA helicase and have a broad-spectrum antibacterial effect. They have strong antibacterial activity against Enterobacter bacteria such as Escherichia coli, Klebsiella, Proteus, Shigella, Salmonella typhi, etc., as well as influenza bacillus and Neisseria. They also have certain antibacterial effects on Staphylococcus aureus and Pseudomonas aeruginosa. They have only mild effects on pneumococci, various groups of streptococci and enterococci.

Quinolone antibacterial drugs inhibit bacterial DNA helicase and have antibacterial effects on Enterobacter, influenza bacillus, Neisseria, Staphylococcus aureus and Pseudomonas aeruginosa, etc. They have only mild effects on pneumococci, streptococci and enterococci.

It can effectively reduce intracranial pressure and intraocular pressure, especially the intracranial pressure.

It can effectively reduce intracranial pressure and intraocular pressure, especially the intracranial pressure.

It strengthens the function of the brainstem reticular formation, especially the ascending reticular formation excitatory system which is closely related to consciousness; strengthens the function of the vertebral system and improves motor paralysis; improves cerebral circulation and promotes brain metabolism by reducing cerebral blood flow resistance and increasing cerebral blood flow, which has a certain effect on promoting brain function recovery and awakening.

This product has good antibacterial effect on superficial fungi such as Trichophyton, Microsporum, Epidermophyton, etc. It has no antibacterial effect on Candida, Cryptococcus, Histoplasma, Sporothrix, Blastomyces, Coccidioides, etc. This drug inhibits the growth of fungi by interfering with the synthesis of fungal nucleic acids.